Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration

ZY Wang, KK Zhao, ZM Song, LJ Shen, J Qu - Medical hypotheses, 2009 - Elsevier
The purpose of this article is to propose a novel therapeutic approach to the treatment of age-
related macular degeneration (ARMD), the leading cause of blindness in the elderly
population (over 60 years of age) in developed countries. Although recent advances have
been made in the treatment of the neovascular form of ARMD, there is still no effective
treatment for the most prevalent atrophic form of ARMD. Although the exact etiology and
molecular pathogenesis of the atrophic ARMD are not fully understood, it is believed that …